ProPhase Labs, Inc.
PRPH
$0.10
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -47.52% | -37.64% | -17.09% | -39.26% | 125.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -47.52% | -37.64% | -17.09% | -39.26% | 125.32% |
| Cost of Revenue | -67.34% | -16.24% | -69.08% | -62.54% | 176.04% |
| Gross Profit | 264.67% | -157.21% | 573.55% | 976.67% | 95.99% |
| SG&A Expenses | -65.03% | -29.48% | -33.30% | -43.94% | 145.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -65.34% | -28.48% | -41.12% | -48.99% | 271.37% |
| Operating Income | 66.88% | 26.48% | 46.13% | 52.00% | -57.77% |
| Income Before Tax | 57.83% | 6.38% | 52.35% | 42.18% | -68.84% |
| Income Tax Expenses | -104.27% | 93.74% | 134.06% | -- | 599.52% |
| Earnings from Continuing Operations | 77.96% | -37.74% | 18.14% | 15.31% | -302.12% |
| Earnings from Discontinued Operations | 100.00% | -- | -- | 1,266.53% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 78.47% | -3.83% | 27.32% | 163.30% | -292.63% |
| EBIT | 66.88% | 26.48% | 46.13% | 52.00% | -57.77% |
| EBITDA | 69.79% | 24.83% | 55.29% | 63.81% | -68.74% |
| EPS Basic | 97.67% | 52.32% | 66.95% | 132.42% | -186.08% |
| Normalized Basic EPS | 94.62% | 55.65% | 84.85% | 73.11% | -20.77% |
| EPS Diluted | 97.67% | 52.32% | 66.31% | 132.42% | -186.71% |
| Normalized Diluted EPS | 94.62% | 55.65% | 84.85% | 73.11% | -20.77% |
| Average Basic Shares Outstanding | 822.17% | 117.73% | 119.93% | 95.25% | 39.39% |
| Average Diluted Shares Outstanding | 822.17% | 117.73% | 119.93% | 95.25% | 39.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |